A doctor who leaked confidential information about Eli Lillys antipsychotic medication Zyprexa has agreed to terms of a financial settlement with the drugmaker, The New York Times reports.

Merck scored a major legal victory yesterday when New Jerseys Supreme Court rejected a class action lawsuit against the company over its withdrawn pain medication Vioxx.

A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales reps in a $100 million class-action lawsuit.

Three firms are challenging Maine and Vermont over new state laws that restrict the collection and disclosure of physician prescribing information.

Pfizer will look to re-submit corrections to its US Lipitor patent after the US Patent and Trademark Office rebuffed an initial attempt.

As the FDA keeps up the pressure on marketers for making unsubstantiated claims in their professional promotions, a Pfizer legal expert says companies may be able to avoid such notices by supporting all advertising claims with substantial evidence.

A legal battle is under way between Johnson Johnson and the American Red Cross involving the use of the iconic red cross logo that is currently used by both organizations.

A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales employees in a $100 million class-action lawsuit.

Generics drug firm Ranbaxy Laboratories said it has reached an agreement with GlaxoSmithKline resulting in a dismissal of US patent litigation regarding Glaxos herpes pill Valtrex (valacyclovir hydrochloride).

Two former Abbott Laboratories sales reps have sued the company in federal court in Chicago, claiming the drugmaker denied them overtime wages.